Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer
Uloženo v:
| Název: | Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer |
|---|---|
| Autoři: | Angela Alibrandi, Massimiliano Siracusa, Alfredo Campennì, Giovanni Tuccari, Angiola Saccomanno, Luca Giovanella, Giulia Giacoppo, Sergio Baldari, Gianlorenzo Dionigi, Rosaria Maddalena Ruggeri, Flavia La Torre |
| Zdroj: | European Journal of Endocrinology. 185:397-404 |
| Informace o vydavateli: | Oxford University Press (OUP), 2021. |
| Rok vydání: | 2021 |
| Témata: | Adult, Aged, 80 and over, Male, 0301 basic medicine, Adolescent, Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Retrospective Studies, Risk Factors, Thyroid Neoplasms, Thyroid Nodule, Thyroidectomy, Treatment Outcome, Young Adult, Middle Aged, 3. Good health, Young Adult, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Aged, 80 and over, Child, Female, Humans, Neoplasm Recurrence, Local, Retrospective Studies, Risk Factors, Thyroid Neoplasms, Thyroid Nodule, Thyroidectomy, Neoplasm Recurrence, Local |
| Popis: | Aim The risk of differentiated thyroid cancer (DTC) recurrence is widely evaluated according to the 2015 ATA Risk Stratification System. Topography of malignant nodules has been previously reported as an additional risk factor but is not included in the ATA system. Thus, our study aimed to evaluate the relationship between DTC topography and response to initial therapy. Patients and methods: We enrolled 401 low- to intermediate-risk patients with DTC who had undergone thyroidectomy and radioiodine therapy. DTC topography was recorded and compared with the response to therapy as assessed 12 months after the end of therapy. Results Overall, 366/401 (91.3%) patients had an excellent response to initial therapy while 22/401 (5.5%) and 13/401 (3.2%) had incomplete biochemical or structural responses, respectively. Incomplete response occurred in 10/36 (27.8%), 5/125 (4.0%), and 4/111 (3.6%) patients whose unifocal malignant nodules were located in the isthmus, right lobe, or left lobe. Incomplete response was also observed in 4/54 (7.4%) and 12/75 (16%) patients carrying multifocal cancers in one or both lobes, respectively. Patients with isthmic cancer more frequently demonstrated incomplete response compared with those who had cancer in other locations (P = 0.00). No significant relationship was found with age, gender, maximum size of malignant nodule, Hashimoto’s thyroiditis, vascular invasion, and extrathyroidal extension (P = 0.78, P = 0.77, P = 0.52, P = 0.19, P = 0.73, and P = 0.26, respectively). The risk of incomplete response was about 65% higher in patients with isthmic lesions compared with other patients (odds ratio = 6.725). A log-rank test demonstrated that disease-free survival (DFS) of patients with isthmic lesions was significantly shorter than that of other patients (P = 0.02). Conclusion Our data show that isthmus topography of malignant thyroid nodules is a risk factor for having both persistent disease 12 months after primary treatment and reduced DFS. |
| Druh dokumentu: | Article |
| Popis souboru: | application/pdf |
| ISSN: | 1479-683X 0804-4643 |
| DOI: | 10.1530/eje-21-0328 |
| Přístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/34232125 https://pubmed.ncbi.nlm.nih.gov/34232125/ https://eje.bioscientifica.com/view/journals/eje/185/3/EJE-21-0328.xml https://www.ncbi.nlm.nih.gov/pubmed/34232125 https://hdl.handle.net/11570/3211885 https://doi.org/10.1530/EJE-21-0328 https://academic.oup.com/ejendo/article-abstract/185/3/397/6654490?redirectedFrom=fulltext&login=true |
| Přístupové číslo: | edsair.doi.dedup.....68962e84d10c4c39c673865c33c3352c |
| Databáze: | OpenAIRE |
Nájsť tento článok vo Web of Science | Abstrakt: | Aim The risk of differentiated thyroid cancer (DTC) recurrence is widely evaluated according to the 2015 ATA Risk Stratification System. Topography of malignant nodules has been previously reported as an additional risk factor but is not included in the ATA system. Thus, our study aimed to evaluate the relationship between DTC topography and response to initial therapy. Patients and methods: We enrolled 401 low- to intermediate-risk patients with DTC who had undergone thyroidectomy and radioiodine therapy. DTC topography was recorded and compared with the response to therapy as assessed 12 months after the end of therapy. Results Overall, 366/401 (91.3%) patients had an excellent response to initial therapy while 22/401 (5.5%) and 13/401 (3.2%) had incomplete biochemical or structural responses, respectively. Incomplete response occurred in 10/36 (27.8%), 5/125 (4.0%), and 4/111 (3.6%) patients whose unifocal malignant nodules were located in the isthmus, right lobe, or left lobe. Incomplete response was also observed in 4/54 (7.4%) and 12/75 (16%) patients carrying multifocal cancers in one or both lobes, respectively. Patients with isthmic cancer more frequently demonstrated incomplete response compared with those who had cancer in other locations (P = 0.00). No significant relationship was found with age, gender, maximum size of malignant nodule, Hashimoto’s thyroiditis, vascular invasion, and extrathyroidal extension (P = 0.78, P = 0.77, P = 0.52, P = 0.19, P = 0.73, and P = 0.26, respectively). The risk of incomplete response was about 65% higher in patients with isthmic lesions compared with other patients (odds ratio = 6.725). A log-rank test demonstrated that disease-free survival (DFS) of patients with isthmic lesions was significantly shorter than that of other patients (P = 0.02). Conclusion Our data show that isthmus topography of malignant thyroid nodules is a risk factor for having both persistent disease 12 months after primary treatment and reduced DFS. |
|---|---|
| ISSN: | 1479683X 08044643 |
| DOI: | 10.1530/eje-21-0328 |